CFD merupakan instrumen yang rumit dan memiliki risiko tinggi kehilangan uang secara cepat karena adanya pengaruh leverage. 84% akun investor ritel mengalami kerugian saat melakukan kegiatan perdagangan CFD dengan penyedia ini. Anda harus mempertimbangkan apakah Anda memahami cara kerja CFD dan apakah Anda mampu menerima risiko tinggi kehilangan uang.
Capital Com Australia Pty Ltd Australia (Regulated by ASIC) Capital Com UK Limited Authorised and regulated by the Financial Conduct Authority (FCA) Capital Com SV Investments Limited Cyprus / EU (Regulated by CYSEC) Сlosed Joint Stock Company «FinTech Solutions» (Regulated by NBRB) Smart Forex Broker LLC Capital Com Stock and CFD Investing Ltd Seychelles (Regulated by FSA) Capital Com Online Investments Ltd (Regulated by SCB) Our Global Offices

Scan to Download iOS&Android APP

English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文
Anda juga dapat menghubungi kami: hubungi +44 2030978888 support@capital.com

Perdagangan SEELOS THERAPEUTICS INC - SEEL CFD

0.7090
7.52%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.0212
Biaya inap posisi Long

Long position overnight fee

Margin. Your investment $1,000.00
Biaya Overnight -0.024068 %
Charges from borrowed part ($-0.96)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
Kunjungi platform
-0.024068%
Biaya inap posisi short

Short position overnight fee

Margin. Your investment $1,000.00
Biaya Overnight 0.001846 %
Charges from borrowed part ($0.07)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
Kunjungi platform
0.001846%
Waktu biaya inap 21:00 (UTC)
Kuantitas min. yang diperdagangkan 1
Mata uang USD
Margin 20%
Bursa efek United States of America
Komisi perdagangan 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 0.6594
Open* 0.6862
1-Year Change* -26.22%
Day's Range* 0.6762 - 0.7189
52 wk Range 0.48-1.52
Average Volume (10 days) 815.43K
Average Volume (3 months) 12.56M
Market Cap 80.36M
P/E Ratio -100.00K
Shares Outstanding 121.28M
Revenue N/A
EPS -0.69
Dividend (Yield %) N/A
Beta 1.80
Next Earnings Date N/A

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Mar 20, 2023 0.6594 -0.0029 -0.44% 0.6623 0.6815 0.6366
Mar 17, 2023 0.6635 -0.0127 -1.88% 0.6762 0.6884 0.6599
Mar 16, 2023 0.6672 0.0258 4.02% 0.6414 0.6894 0.6297
Mar 15, 2023 0.6224 -0.0737 -10.59% 0.6961 0.6994 0.6090
Mar 14, 2023 0.6658 0.0173 2.67% 0.6485 0.6789 0.6192
Mar 13, 2023 0.6358 0.0068 1.08% 0.6290 0.6554 0.5990
Mar 10, 2023 0.6396 0.0606 10.47% 0.5790 0.6535 0.5647
Mar 9, 2023 0.5792 -0.0374 -6.07% 0.6166 0.6166 0.5790
Mar 8, 2023 0.6030 -0.0235 -3.75% 0.6265 0.6265 0.5990
Mar 7, 2023 0.6194 -0.0568 -8.40% 0.6762 0.6762 0.6040
Mar 6, 2023 0.6520 -0.0484 -6.91% 0.7004 0.7004 0.6475
Mar 3, 2023 0.6901 -0.0122 -1.74% 0.7023 0.7181 0.6789
Mar 2, 2023 0.6876 -0.0194 -2.74% 0.7070 0.7311 0.6697
Mar 1, 2023 0.7218 -0.0737 -9.26% 0.7955 0.7988 0.7218
Feb 28, 2023 0.7803 0.0663 9.29% 0.7140 0.7988 0.6798
Feb 27, 2023 0.7107 0.0243 3.54% 0.6864 0.7434 0.6683
Feb 24, 2023 0.6689 -0.0173 -2.52% 0.6862 0.6957 0.6602
Feb 23, 2023 0.6947 -0.0223 -3.11% 0.7170 0.7209 0.6794
Feb 22, 2023 0.6995 -0.0214 -2.97% 0.7209 0.7260 0.6969
Feb 21, 2023 0.7103 -0.0256 -3.48% 0.7359 0.7359 0.6989

SEELOS THERAPEUTICS INC Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Total revenue 0 0 0.375 0 0
Total Operating Expense 63.907 18.759 30.122 3.184 11.097
Selling/General/Admin. Expenses, Total 15.02 7.775 7.559 2.631 7.21
Research & Development 46.649 10.984 22.563 0.553 3.463
Unusual Expense (Income) 2.238 0.424
Operating Income -63.907 -18.759 -29.747 -3.184 -11.097
Interest Income (Expense), Net Non-Operating -1.854 -0.119 0.013 -0.291 -0.083
Other, Net -0.287 -0.223 -21.521 0 -0.569
Net Income Before Taxes -66.048 -19.101 -51.255 -3.475 -11.749
Net Income After Taxes -66.048 -19.101 -51.255 -3.475 -11.749
Net Income Before Extra. Items -66.048 -19.101 -51.255 -3.475 -11.749
Total Extraordinary Items 12.07
Net Income -66.048 -19.101 -51.255 -3.475 0.321
Income Available to Common Excl. Extra. Items -66.048 -19.101 -51.255 -3.475 -11.749
Income Available to Common Incl. Extra. Items -66.048 -19.101 -51.255 -3.475 0.321
Diluted Net Income -66.048 -19.101 -51.255 -3.475 0.321
Diluted Weighted Average Shares 90.8901 44.7666 20.3088 3.08155 0.3964
Diluted EPS Excluding Extraordinary Items -0.72668 -0.42668 -2.52378 -1.12768 -29.6392
Diluted Normalized EPS -0.70206 -0.42668 -2.52378 -1.12768 -28.5696
Revenue 0 0.375 0
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Total revenue 0 0 0 0 0
Total Operating Expense 14.01 27.374 10.91 9.011 16.612
Selling/General/Admin. Expenses, Total 4.001 7.828 2.227 2.465 2.5
Research & Development 10.009 19.546 8.683 4.308 14.112
Operating Income -14.01 -27.374 -10.91 -9.011 -16.612
Interest Income (Expense), Net Non-Operating 0.019 -0.348 0.019 -0.554 -0.971
Other, Net -0.01 0.463 0.076 0.707 -1.533
Net Income Before Taxes -14.001 -27.259 -10.815 -8.858 -19.116
Net Income After Taxes -14.001 -27.259 -10.815 -8.858 -19.116
Net Income Before Extra. Items -14.001 -27.259 -10.815 -8.858 -19.116
Net Income -14.001 -27.259 -10.815 -8.858 -19.116
Income Available to Common Excl. Extra. Items -14.001 -27.259 -10.815 -8.858 -19.116
Income Available to Common Incl. Extra. Items -14.001 -27.259 -10.815 -8.858 -19.116
Diluted Net Income -14.001 -27.259 -10.815 -8.858 -19.116
Diluted Weighted Average Shares 105.53 103.821 102.325 87.9955 69.0533
Diluted EPS Excluding Extraordinary Items -0.13267 -0.26256 -0.10569 -0.10066 -0.27683
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.13267 -0.26256 -0.10569 -0.07523 -0.27683
Unusual Expense (Income) 0 0 2.238
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Total Current Assets 83.461 17.494 11.096 0.191 6.592
Cash and Short Term Investments 78.734 15.662 10.261 0.042 6.331
Cash & Equivalents 6.331
Prepaid Expenses 4.54 1.832 0.835 0.009 0.261
Other Current Assets, Total 0.187 0 0.14 0
Total Assets 83.5 17.494 11.096 0.191 6.706
Property/Plant/Equipment, Total - Net 0.039 0.079
Property/Plant/Equipment, Total - Gross 0.521
Accumulated Depreciation, Total -0.442
Other Long Term Assets, Total 0.035
Total Current Liabilities 8.287 7.429 10.778 4.897 1.583
Accounts Payable 1.693 1.887 0.796 2.22 0.058
Accrued Expenses 3.766 1.924 1.919 0.235 1.513
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 1.798 1.187 8.063 0 0.012
Total Liabilities 26.177 14.922 11.103 4.897 2.335
Total Long Term Debt 17.89 7.293 0 0 0
Other Liabilities, Total 0 0.2 0.325 0 0.752
Total Equity 57.323 2.572 -0.007 -4.706 4.371
Preferred Stock - Non Redeemable, Net 0 0 0 0
Common Stock 0.105 0.054 0.027 0.003 0.015
Additional Paid-In Capital 198.428 77.68 56.027 0.097 320.343
Retained Earnings (Accumulated Deficit) -141.21 -75.162 -56.061 -4.806 -315.987
Total Liabilities & Shareholders’ Equity 83.5 17.494 11.096 0.191 6.706
Total Common Shares Outstanding 105.5 54.5359 27.0285 3.08155 0.50719
Cash 78.734 15.662 10.261 0.042
Current Port. of LT Debt/Capital Leases 1.03 2.431 0 2.442
Long Term Debt 17.89 7.293
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Total Current Assets 70.667 83.461 80.895 90.246 41.296
Cash and Short Term Investments 61.772 78.734 76.833 87.2 38.687
Cash 61.772 78.734 76.833 87.2 38.687
Prepaid Expenses 8.481 4.727 4.062 3.046 2.609
Total Assets 70.693 83.5 80.946 90.309 41.37
Property/Plant/Equipment, Total - Net 0.026 0.039 0.051 0.063 0.074
Total Current Liabilities 10.13 8.287 8.034 7.595 13.338
Accounts Payable 2.127 1.693 3.401 1.038 1.628
Accrued Expenses 3.575 3.766 3.776 2.62 1.774
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 4.238 1.03 0 0.004 2.296
Other Current Liabilities, Total 0.19 1.798 0.857 3.933 7.64
Total Liabilities 25.056 26.177 8.034 7.611 16.61
Total Long Term Debt 14.926 17.89 0 0.004 3.247
Long Term Debt 14.926 17.89 0 0.004 3.247
Other Liabilities, Total 0 0 0.012 0.025
Total Equity 45.637 57.323 72.912 82.698 24.76
Preferred Stock - Non Redeemable, Net 0 0 0
Common Stock 0.105 0.105 0.102 0.102 0.078
Additional Paid-In Capital 200.743 198.428 186.761 185.732 118.96
Retained Earnings (Accumulated Deficit) -155.211 -141.21 -113.951 -103.136 -94.278
Total Liabilities & Shareholders’ Equity 70.693 83.5 80.946 90.309 41.37
Total Common Shares Outstanding 105.591 105.5 102.355 102.272 78.283
Other Current Assets, Total 0.414
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Net income/Starting Line -66.048 -19.101 -51.255 -3.475 0.321
Cash From Operating Activities -48.995 -20.913 -19.305 -1.581 -10.466
Cash From Operating Activities 0.117
Non-Cash Items 18.46 2.733 25.089 0.193 -9.701
Cash Taxes Paid 0 0 0 0 0
Cash Interest Paid 0.01 0.011 0.016 0 0.092
Changes in Working Capital -1.407 -4.545 6.861 1.701 -1.203
Cash From Investing Activities 12.209
Capital Expenditures 0
Other Investing Cash Flow Items, Total 12.209
Cash From Financing Activities 112.067 26.314 29.524 1.365 2.501
Issuance (Retirement) of Stock, Net 125.618 15.26 29.524 0 9.63
Issuance (Retirement) of Debt, Net -13.551 11.054 0 1.365 -7.129
Net Change in Cash 63.072 5.401 10.219 -0.216 4.244
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line -14.001 -66.048 -38.789 -27.974 -19.116
Cash From Operating Activities -17.045 -48.995 -30.656 -20.146 -11.252
Non-Cash Items 2.242 18.46 7.171 6.372 3.224
Cash Taxes Paid 0 0 0 0
Cash Interest Paid 0.004 0.01 0.01 0.008 0.004
Changes in Working Capital -5.286 -1.407 0.962 1.456 4.64
Cash From Financing Activities 0.083 112.067 91.827 91.684 34.277
Issuance (Retirement) of Stock, Net 0.083 125.618 105.378 105.304 39.444
Issuance (Retirement) of Debt, Net 0 -13.551 -13.551 -13.62 -5.167
Net Change in Cash -16.962 63.072 61.171 71.538 23.025
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 4.1366 5016741 2401 2022-12-31 LOW
Tontine Asset Management, LLC Hedge Fund 4.0475 4908725 0 2022-12-31 MED
Mehra Raj Individual Investor 2.5396 3079929 66667 2022-03-31
BlackRock Institutional Trust Company, N.A. Investment Advisor 1.4732 1786610 10506 2022-12-31 LOW
Group One Trading, L.P. Research Firm 1.0614 1287189 -874776 2022-12-31 HIGH
Mirae Asset Global Investments (USA) LLC Investment Advisor 1.0162 1232463 -528151 2022-12-31 LOW
Horizons ETFs Management (Canada) Inc. Investment Advisor/Hedge Fund 1.0162 1232463 0 2023-01-31 LOW
Uniplan Investment Counsel, Inc. Investment Advisor 0.9709 1177510 -1307817 2022-12-31 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.9201 1115883 8054 2022-12-31 LOW
MAI Capital Management, LLC Investment Advisor/Hedge Fund 0.8427 1022008 -208802 2022-12-31 LOW
Modera Wealth Management, LLC Investment Advisor/Hedge Fund 0.7186 871505 871505 2022-12-31 LOW
Oasis Management Company Ltd. Investment Advisor/Hedge Fund 0.7009 850000 0 2022-12-31 LOW
Millennium Management LLC Hedge Fund 0.6168 747985 -171083 2022-12-31 HIGH
AdvisorShares Investments, LLC Investment Advisor 0.3076 373083 -97068 2022-12-31 HIGH
Morgan Stanley Smith Barney LLC Investment Advisor 0.2778 336938 27284 2022-12-31 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.2592 314405 0 2022-12-31 LOW
Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.1514 183651 0 2022-12-31 LOW
Davenport Asset Management Investment Advisor 0.1117 135500 0 2022-12-31 LOW
GSA Capital Partners LLP Hedge Fund 0.0866 105050 -32216 2022-12-31 HIGH
Strategic Family Wealth Counselors, L.L.C Investment Advisor 0.0841 102000 102000 2022-12-31 LOW

Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.

Capital.com Group

500K+

Trader

92K+

Klien aktif per bulan

$53M+

Volume investasi per bulan

$30M+

Penarikan tiap bulan

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long
Past performance is not a reliable indicator of future results
Laba/Loss
Industry: Pharmaceuticals (NEC)

300 Park Avenue
2Nd Floor
NEW YORK
NEW YORK 10022
US

Income Statement

  • Annual
  • Quarterly

People also watch

Gold

1,940.68 Price
-1.940% 1D Chg, %
Biaya inap posisi Long -0.0177%
Biaya inap posisi short 0.0095%
Waktu biaya inap 21:00 (UTC)
Spread 0.33

BTC/USD

28,053.30 Price
-0.130% 1D Chg, %
Biaya inap posisi Long -0.0616%
Biaya inap posisi short 0.0137%
Waktu biaya inap 21:00 (UTC)
Spread 66.00

Oil - Crude

69.53 Price
+2.460% 1D Chg, %
Biaya inap posisi Long -0.0194%
Biaya inap posisi short -0.0026%
Waktu biaya inap 21:00 (UTC)
Spread 0.03

US100

12,742.70 Price
+1.380% 1D Chg, %
Biaya inap posisi Long -0.0241%
Biaya inap posisi short 0.0018%
Waktu biaya inap 21:00 (UTC)
Spread 3.0

Masih mencari broker yang bisa Anda percayai?

Bergabung dengan 500.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com

1. Buat & verifikasi akun Anda 2. Lakukan deposit 3. Temukan trading Anda